370 related articles for article (PubMed ID: 7477352)
21. T cell activation induced by novel gain-of-function mutants of Syk and ZAP-70.
Zeitlmann L; Knorr T; Knoll M; Romeo C; Sirim P; Kolanus W
J Biol Chem; 1998 Jun; 273(25):15445-52. PubMed ID: 9624129
[TBL] [Abstract][Full Text] [Related]
22. The Syk and ZAP-70 SH2-containing tyrosine kinases are implicated in pre-T cell receptor signaling.
Cheng AM; Negishi I; Anderson SJ; Chan AC; Bolen J; Loh DY; Pawson T
Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9797-801. PubMed ID: 9275205
[TBL] [Abstract][Full Text] [Related]
23. Molecular cloning of human Syk. A B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex.
Law CL; Sidorenko SP; Chandran KA; Draves KE; Chan AC; Weiss A; Edelhoff S; Disteche CM; Clark EA
J Biol Chem; 1994 Apr; 269(16):12310-9. PubMed ID: 8163536
[TBL] [Abstract][Full Text] [Related]
24. Harnessing Syk family tyrosine kinases as signaling domains for chimeric single chain of the variable domain receptors: optimal design for T cell activation.
Fitzer-Attas CJ; Schindler DG; Waks T; Eshhar Z
J Immunol; 1998 Jan; 160(1):145-54. PubMed ID: 9551966
[TBL] [Abstract][Full Text] [Related]
25. Distinct T cell developmental consequences in humans and mice expressing identical mutations in the DLAARN motif of ZAP-70.
Elder ME; Skoda-Smith S; Kadlecek TA; Wang F; Wu J; Weiss A
J Immunol; 2001 Jan; 166(1):656-61. PubMed ID: 11123350
[TBL] [Abstract][Full Text] [Related]
26. Disruption of epithelial gamma delta T cell repertoires by mutation of the Syk tyrosine kinase.
Mallick-Wood CA; Pao W; Cheng AM; Lewis JM; Kulkarni S; Bolen JB; Rowley B; Tigelaar RE; Pawson T; Hayday AC
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9704-9. PubMed ID: 8790395
[TBL] [Abstract][Full Text] [Related]
27. The role of the Syk/Shp-1 kinase-phosphatase equilibrium in B cell development and signaling.
Alsadeq A; Hobeika E; Medgyesi D; Kläsener K; Reth M
J Immunol; 2014 Jul; 193(1):268-76. PubMed ID: 24899508
[TBL] [Abstract][Full Text] [Related]
28. Syk expression in endothelial cells and their morphologic defects in embryonic Syk-deficient mice.
Yanagi S; Inatome R; Ding J; Kitaguchi H; Tybulewicz VL; Yamamura H
Blood; 2001 Nov; 98(9):2869-71. PubMed ID: 11675365
[TBL] [Abstract][Full Text] [Related]
29. Differential intrinsic enzymatic activity of Syk and Zap-70 protein-tyrosine kinases.
Latour S; Chow LM; Veillette A
J Biol Chem; 1996 Sep; 271(37):22782-90. PubMed ID: 8798454
[TBL] [Abstract][Full Text] [Related]
30. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells.
Coopman PJ; Do MT; Barth M; Bowden ET; Hayes AJ; Basyuk E; Blancato JK; Vezza PR; McLeskey SW; Mangeat PH; Mueller SC
Nature; 2000 Aug; 406(6797):742-7. PubMed ID: 10963601
[TBL] [Abstract][Full Text] [Related]
31. Cloning of the cDNA for the deleted syk kinase homologous to ZAP-70 from human basophilic leukemia cell line (KU812).
Yagi S; Suzuki K; Hasegawa A; Okumura K; Ra C
Biochem Biophys Res Commun; 1994 Apr; 200(1):28-34. PubMed ID: 7513161
[TBL] [Abstract][Full Text] [Related]
32. Pre-B and pre-T-cell receptors: conservation of strategies in regulating early lymphocyte development.
Muljo SA; Schlissel MS
Immunol Rev; 2000 Jun; 175():80-93. PubMed ID: 10933593
[TBL] [Abstract][Full Text] [Related]
33. Syk deficiency--a knockout for B-cell development.
Harnett M
Immunol Today; 1996 Jan; 17(1):4. PubMed ID: 8652052
[No Abstract] [Full Text] [Related]
34. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer.
Wang L; Duke L; Zhang PS; Arlinghaus RB; Symmans WF; Sahin A; Mendez R; Dai JL
Cancer Res; 2003 Aug; 63(15):4724-30. PubMed ID: 12907655
[TBL] [Abstract][Full Text] [Related]
35. IL-1 induced chemokine production through the association of Syk with TNF receptor-associated factor-6 in nasal fibroblast lines.
Yamada T; Fujieda S; Yanagi S; Yamamura H; Inatome R; Yamamoto H; Igawa H; Saito H
J Immunol; 2001 Jul; 167(1):283-8. PubMed ID: 11418661
[TBL] [Abstract][Full Text] [Related]
36. Premature terminal differentiation protects from deregulated lymphocyte activation by ITK-Syk.
Bach MP; Hug E; Werner M; Holch J; Sprissler C; Pechloff K; Zirlik K; Zeiser R; Dierks C; Ruland J; Jumaa H
J Immunol; 2014 Feb; 192(3):1024-33. PubMed ID: 24376268
[TBL] [Abstract][Full Text] [Related]
37. Tyrosine kinase SYK: essential functions for immunoreceptor signalling.
Turner M; Schweighoffer E; Colucci F; Di Santo JP; Tybulewicz VL
Immunol Today; 2000 Mar; 21(3):148-54. PubMed ID: 10689303
[TBL] [Abstract][Full Text] [Related]
38. Protein-tyrosine kinase, Syk, is required for CXCL12-induced polarization of B cells.
Matsusaka S; Tohyama Y; He J; Shi Y; Hazama R; Kadono T; Kurihara R; Tohyama K; Yamamura H
Biochem Biophys Res Commun; 2005 Mar; 328(4):1163-9. PubMed ID: 15707999
[TBL] [Abstract][Full Text] [Related]
39. Structural requirements of Syk kinase for Fcgamma receptor-mediated phagocytosis.
Hunter S; Sato N; Kim MK; Huang ZY; Chu DH; Park JG; Schreiber AD
Exp Hematol; 1999 May; 27(5):875-84. PubMed ID: 10340404
[TBL] [Abstract][Full Text] [Related]
40. Nontranscriptional regulation of SYK by the coactivator OCA-B is required at multiple stages of B cell development.
Siegel R; Kim U; Patke A; Yu X; Ren X; Tarakhovsky A; Roeder RG
Cell; 2006 May; 125(4):761-74. PubMed ID: 16713566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
